Sfoglia per Autore
Myelodysplastic syndromes
2004-01-01 CILLONI D; MESSA F; CARTURAN S; ARRUGA F; DEFILIPPI I; MESSA E; GOTTARDI E; SAGLIO G
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation
2004-01-01 CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients
2004-01-01 CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; FAVA M; DEFILIPPI I; ARRUGA F; SAGLIO G.
WT1 overexpression: A clinically useful marker in acute and chronic myeloid leukemias
2005-01-01 SAGLIO G; CARTURAN S; GRILLO S; CAPELLA S; ARRUGA F; DEFILIPPI I; ROSSO V; RAUCO M; MARINA LIBERATI A; CILLONI D
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance
2006-01-01 CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; MOROTTI A; MESSA E; CARTURAN S; GIUGLIANO E; PAUTASSO M; BRACCO E.; ROSSO V; SEN A; MARTINELLI G; BACCARANI M; SAGLIO G.
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line
2006-01-01 MOROTTI A; CILLONI D; PAUTASSO M; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO R; ROSSO V; CHIARENZA A; TAULLI R; BRACCO E; REGE-CAMBRIN G; GOTTARDI E; SAGLIO G
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells
2006-01-01 MOROTTI A; CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO; R; ROSSO V; CHIARENZA A; PILATRINO C; GUERRASIO A; TAULLI R; BRACCO E; PAUTASSO; M; BARABAN D; GOTTARDI E; SAGLIO G.
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes
2006-01-01 CILLONI D; MESSA E; MESSA F; CARTURAN S; DEFILIPPI I; ARRUGA F; ROSSO V; CATALANO R; BRACCO E; NICOLI P; SAGLIO G
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia
2007-01-01 CILLONI D; MESSA F; MARTINELLI G; GOTTARDI E; ARRUGA F; DEFILIPPI I; CARTURAN; S; MESSA E; FAVA M; GIUGLIANO E; ROSSO V; CATALANO R; MERANTE S; NICOLI P; RONDONI M; OTTAVIANI E; SOVERINI S; TIRIBELLI M; PANE F; BACCARANI M; SAGLIO G
Identification of different Ikaros cDNAtranscripts in Philadelphia-positive adult acute lymphoblastic leukemia by ahigh-throughput capillary electrophoresis sizing method
2008-01-01 Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G.
Expression of spliced oncogenic Ikaros isoforms inPhiladelphia-positive acute lymphoblastic leukemia patients treated with tyrosinekinase inhibitors: implications for a new mechanism of resistance
2008-01-01 Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G.
Early prediction of treatment outcome in acute myeloid leukemia by measurment of WT1 transcript levels in peripheral blood samples collected after chemotherapy
2008-01-01 Cilloni D.; Messa F.; Arruga F.; Defilippi I.; Gottardi E.; Fava M.; Carturan S.; Catalano R.; Bracco E.; Messa E.; Nicoli P.; Diverio D.; Sanz MA; Martinelli G.; Lo-Coco F.; Saglio G.
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis
2008-01-01 Messa E; Cilloni D; Messa F; Arruga F; Roetto A; Saglio G.
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
2010-01-01 Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators Collaborators (73) Vannucchi AM, Antonioli E, Bartalucci N, Biamonte F, Bogani C, Bosi A, Fjerza R, Guglielmelli P, Malevolti E, Pancrazzi A,Pieri L, Spolverini A, Susini MC, Tozzi L, Bortoluzzi S, Bisognin A, Coppe A, Marchioli R, Barosi G, Azzan C, Badalucco S,Balduini A, Bergamaschi G, Bonetti E, Campanelli R, Carolei A, Currao M, Isgrò MA, Lupo ML, Magrini U, Massa M, Magni V,Rosti V, Villani L, Cazzola M, Bernasconi P, Boggi S, Elena C, Gallì A, Malcovati L, Pascutto C, Passamonti F, Pietra D,Rumi E, Dejana E, Corada M, Giannotta M, Rambaldi A, Ferrari ML, Finazzi G, Finazzi MC, Magri M, Quaresmini G, Montalvo ML, Ricci C, Salmoiraghi S, Spinelli O, Amaru A, Golay J, Cilloni D, Arruga F, Bracco E, Carturan S, Gaidano V, Guerrasio A,Pradotto M, Manfredini R, Bianchi E, Montanari M, Salati S, Tagliafico E, Tenedini E, Zini R
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging
2010-01-01 E. Messa;S. Carturan;C. Maffe;M. Pautasso;E. Bracco;A. Roetto;F. Messa;F. Arruga;I. Defilippi;V. Rosso;C. Zanone;A. Rotolo;E. Greco;R. M. Pellegrino;D. Alberti;G. Saglio;D. Cilloni
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients
2010-01-01 Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G.
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
2012-01-01 Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G.
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.
2013-01-01 Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S.
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.
2014-01-01 F. Arruga; B. Gizdic; S. Serra; T. Vaisitti; C. Ciardullo; M. Coscia; L. Laurenti; G. D'Arena; O. Jaksic; G. Inghirami; D. Rossi; G. Gaidano; S. Deaglio
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism
2014-01-01 Audrito, V; Serra, S; Brusa, D; Mazzola, F; Arruga, F; Vaisitti, T; Coscia, M; Maffei, R; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, S
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Myelodysplastic syndromes | 2004 | CILLONI D; MESSA F; CARTURAN S; ARRUGA F; DEFILIPPI I; MESSA E; GOTTARDI E; SAGLIO G | |
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation | 2004 | CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M; SAGLIO G | |
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients | 2004 | CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; FAVA M; DEFILIPPI I; ARRUGA F; SAGLIO G. | |
WT1 overexpression: A clinically useful marker in acute and chronic myeloid leukemias | 2005 | SAGLIO G; CARTURAN S; GRILLO S; CAPELLA S; ARRUGA F; DEFILIPPI I; ROSSO V; RAUCO M; MARINA LIBERATI A; CILLONI D | |
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance | 2006 | CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; MOROTTI A; MESSA E; CARTURAN S; GIUGLIANO E; PAUTASSO M; BRACCO E.; ROSSO V; SEN A; MARTINELLI G; BACCARANI M; SAGLIO G. | |
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line | 2006 | MOROTTI A; CILLONI D; PAUTASSO M; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO R; ROSSO V; CHIARENZA A; TAULLI R; BRACCO E; REGE-CAMBRIN G; GOTTARDI E; SAGLIO G | |
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells | 2006 | MOROTTI A; CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO; R; ROSSO V; CHIARENZA A; PILATRINO C; GUERRASIO A; TAULLI R; BRACCO E; PAUTASSO; M; BARABAN D; GOTTARDI E; SAGLIO G. | |
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes | 2006 | CILLONI D; MESSA E; MESSA F; CARTURAN S; DEFILIPPI I; ARRUGA F; ROSSO V; CATALANO R; BRACCO E; NICOLI P; SAGLIO G | |
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia | 2007 | CILLONI D; MESSA F; MARTINELLI G; GOTTARDI E; ARRUGA F; DEFILIPPI I; CARTURAN; S; MESSA E; FAVA M; GIUGLIANO E; ROSSO V; CATALANO R; MERANTE S; NICOLI P; RONDONI M; OTTAVIANI E; SOVERINI S; TIRIBELLI M; PANE F; BACCARANI M; SAGLIO G | |
Identification of different Ikaros cDNAtranscripts in Philadelphia-positive adult acute lymphoblastic leukemia by ahigh-throughput capillary electrophoresis sizing method | 2008 | Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G. | |
Expression of spliced oncogenic Ikaros isoforms inPhiladelphia-positive acute lymphoblastic leukemia patients treated with tyrosinekinase inhibitors: implications for a new mechanism of resistance | 2008 | Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G. | |
Early prediction of treatment outcome in acute myeloid leukemia by measurment of WT1 transcript levels in peripheral blood samples collected after chemotherapy | 2008 | Cilloni D.; Messa F.; Arruga F.; Defilippi I.; Gottardi E.; Fava M.; Carturan S.; Catalano R.; Bracco E.; Messa E.; Nicoli P.; Diverio D.; Sanz MA; Martinelli G.; Lo-Coco F.; Saglio G. | |
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis | 2008 | Messa E; Cilloni D; Messa F; Arruga F; Roetto A; Saglio G. | |
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. | 2010 | Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators Collaborators (73) Vannucchi AM, Antonioli E, Bartalucci N, Biamonte F, Bogani C, Bosi A, Fjerza R, Guglielmelli P, Malevolti E, Pancrazzi A,Pieri L, Spolverini A, Susini MC, Tozzi L, Bortoluzzi S, Bisognin A, Coppe A, Marchioli R, Barosi G, Azzan C, Badalucco S,Balduini A, Bergamaschi G, Bonetti E, Campanelli R, Carolei A, Currao M, Isgrò MA, Lupo ML, Magrini U, Massa M, Magni V,Rosti V, Villani L, Cazzola M, Bernasconi P, Boggi S, Elena C, Gallì A, Malcovati L, Pascutto C, Passamonti F, Pietra D,Rumi E, Dejana E, Corada M, Giannotta M, Rambaldi A, Ferrari ML, Finazzi G, Finazzi MC, Magri M, Quaresmini G, Montalvo ML, Ricci C, Salmoiraghi S, Spinelli O, Amaru A, Golay J, Cilloni D, Arruga F, Bracco E, Carturan S, Gaidano V, Guerrasio A,Pradotto M, Manfredini R, Bianchi E, Montanari M, Salati S, Tagliafico E, Tenedini E, Zini R | |
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging | 2010 | E. Messa;S. Carturan;C. Maffe;M. Pautasso;E. Bracco;A. Roetto;F. Messa;F. Arruga;I. Defilippi;V. Rosso;C. Zanone;A. Rotolo;E. Greco;R. M. Pellegrino;D. Alberti;G. Saglio;D. Cilloni | |
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients | 2010 | Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G. | |
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. | 2012 | Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G. | |
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. | 2013 | Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S. | |
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. | 2014 | F. Arruga; B. Gizdic; S. Serra; T. Vaisitti; C. Ciardullo; M. Coscia; L. Laurenti; G. D'Arena; O. Jaksic; G. Inghirami; D. Rossi; G. Gaidano; S. Deaglio | |
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism | 2014 | Audrito, V; Serra, S; Brusa, D; Mazzola, F; Arruga, F; Vaisitti, T; Coscia, M; Maffei, R; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile